Publication Name	World Journal of Gastroenterology
Manuscript ID	6840
Country	Italy

Received	2013-10-29 13:24
Peer-Review Started	2013-10-29 18:15
To Make the First Decision	2013-12-16 17:40
Return for Revision	2013-12-18 15:55
Revised	2014-01-27 21:37
Second Decision	2014-04-16 11:12
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-04-16 12:21
Articles in Press	2014-05-23 10:09
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-06-25 15:56
Publish the Manuscript Online	2014-07-21 17:17

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Bone marrow derived stem cells for the treatment of end-stage liver disease
Manuscript Source	Invited Manuscript
All Author List	Cristina Margini, Ranka Vukotic, Lucia Brodosi, Mauro Bernardi and Pietro Andreone
Funding Agency and Grant Number
Corresponding Author	Pietro Andreone, MD, Professor of Internal Medicine, Dipartimento di Scienze mediche e Chirurgiche, Unità Operativa di Semeiotica Medica, University of Bologna, Padiglione 11, Via Massarenti 9, 40138 Bologna, Italy. pietro.andreone@unibo.it
Key Words	Liver cirrhosis; Liver regeneration; Hematopoietic stem cells; Mesenchymal stem cells; End stage liver disease
Core Tip	In recent years, the role of bone marrow stem cells (BMSCs) in liver regeneration has been explored in various clinical trials. Because these trials were very diverse, we conducted a descriptive overview to understand the effects of BMSC transplantation on liver histology and morphology, on laboratory parameters and prognostic scores, and finally, on clinical manifestations and quality of life. This overview suggests that the efficacy of BMSC therapy might be temporary, and therefore, repeated cycles of BMSCs could be useful to achieve a sustained benefit.
Publish Date	2014-07-21 17:17
Citation	Margini C, Vukotic R, Brodosi L, Bernardi M, Andreone P. Bone marrow derived stem cells for the treatment of end-stage liver disease. World J Gastroenterol 2014; 20(27): 9098-9105
URL	http://www.wjgnet.com/1007-9327/full/v20/i27/9098.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i27.9098

Full Article (PDF)	WJG-20-9098.pdf
Full Article (Word)	WJG-20-9098.doc
Manuscript File	6840-Review.doc
Answering Reviewers	6840-Answering reviewers.pdf
Copyright License Agreement	6840-Copyright_assignment.pdf
Non-Native Speakers of English Editing Certificate	6840-Language certificate.pdf
Peer-review Report	6840-Peer reviewer(s).pdf
Scientific Editor Work List	6840-Scientific editor work list.doc